Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomics. 2022

Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong 518020, PR China; Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China.

Lysine acetylation (Kac) on histone promotes relaxation of the chromatin conformation and favors gene transcription to regulate oncogenesis, whereas the total acetylation profiling of oral squamous cell carcinoma (OSCC) is unknown. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was utilised to investigate lysine acetylation features of tumor tissues and adjacent normal tissues from 9 patients with OCSS. 282 upregulated Kac sites in 234 proteins and 235 downregulated Kac sites in 162 proteins between OSCC tissues and paired adjacent normal tissues were identified. Different acetylation proteins (DAPs) were analyzed through KEGG-based and MCODE. These DAPs are enriched in the ribosome biogenesis pathway. Survival Analysis of hub genes with TCGA database was performed. In addition, IPA software was used to explore the connection between 9 core DAPs (RPS3, RPL24, RPL19, EIF4A2, RPL12, MYBPC1, RPS6, ARCN1, and TMEM9) and the different expression of KATs and KDACs identified in our proteomic. The study is the first comparative study of Kac modification on oral squamous cell carcinoma. We propose to put forward the hypothesis that the dysfunction of ribosome biogenesis caused by the change of Lysine acetylation, especially downregulated acetylation on RPS6 and RPS3 may associated with the pathogenesis of OSCC. SIGNIFICANCE: The study is the first comparative study of Kac modification on oral squamous cell carcinoma through LC-MS/MS-based modified proteomic. These DAPs are high enriched in the ribosome biogenesis pathway. Used MCODE and survival analysis, 9 core DAPs (RPS3, RPL24, RPL19, EIF4A2, RPL12, MYBPC1, RPS6, ARCN1, and TMEM9) were screened. IPA software was used to explore the connection between 9 core DAPs and the different expression of KATs and KDACs identified in our proteomic. In addition, we propose to put forward the hypothesis that the dysfunction of ribosome biogenesis caused by the change of Lysine acetylation, especially downregulated acetylation on RPS6 and RPS3 may associated with the pathogenesis of OSCC.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D012269 Ribosomal Proteins Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits. Proteins, Ribosomal,Ribosomal Protein,Protein, Ribosomal
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D020543 Proteome The protein complement of an organism coded for by its genome. Proteomes

Related Publications

Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
January 2020, Cancer cell international,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
April 2013, Proceedings of the National Academy of Sciences of the United States of America,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
May 2022, Journal of proteomics,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
January 2018, mSystems,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
January 2019, Clinical proteomics,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
July 2017, British journal of cancer,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
January 2004, Proteomics,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
March 2013, Journal of pharmaceutical and biomedical analysis,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
November 2018, Oral oncology,
Jingjing Dong, and Jingquan He, and Zeyu Zhang, and Wei Zhang, and Yixi Li, and Dandan Li, and Hongliang Xie, and Wenxin Zuo, and Jianming Tang, and Zhipeng Zeng, and Wanxia Cai, and Liusheng Lai, and Manhua Yun, and Lingjun Shen, and Lianghong Yin, and Donge Tang, and Yong Dai
September 2009, Cancer science,
Copied contents to your clipboard!